Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
333 | 3 | P53//RETINOBLASTOMA//MDM2 | 37839 |
454 | 2 | CELL CYCLE//CYCLIN DEPENDENT KINASE//E2F | 16304 |
33652 | 1 | CYCLIN G2//CCNG2//CYCLIN G1 | 135 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CYCLIN G2 | authKW | 1883232 | 8% | 73% | 11 |
2 | CCNG2 | authKW | 1719106 | 7% | 82% | 9 |
3 | CYCLIN G1 | authKW | 1694447 | 11% | 48% | 15 |
4 | CYCLIN G | authKW | 1667561 | 7% | 71% | 10 |
5 | PATHOTROPIC TARGETING | authKW | 933837 | 3% | 100% | 4 |
6 | TARGETED GENETIC MEDICINE | authKW | 466919 | 1% | 100% | 2 |
7 | PP2A B GAMMA | authKW | 311278 | 1% | 67% | 2 |
8 | ANTISENSE CYCLIN G1 | authKW | 233459 | 1% | 100% | 1 |
9 | ASPB10 INSULIN X10 | authKW | 233459 | 1% | 100% | 1 |
10 | CYCLIN FAMILY | authKW | 233459 | 1% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 782 | 40% | 0% | 54 |
2 | Cell Biology | 452 | 30% | 0% | 41 |
3 | Genetics & Heredity | 310 | 21% | 0% | 28 |
4 | Biochemistry & Molecular Biology | 111 | 27% | 0% | 36 |
5 | Biotechnology & Applied Microbiology | 85 | 12% | 0% | 16 |
6 | Medicine, Research & Experimental | 58 | 9% | 0% | 12 |
7 | Gastroenterology & Hepatology | 13 | 4% | 0% | 5 |
8 | Obstetrics & Gynecology | 7 | 3% | 0% | 4 |
9 | Nanoscience & Nanotechnology | 4 | 3% | 0% | 4 |
10 | Chemistry, Medicinal | 3 | 2% | 0% | 3 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DIGESTOL INTERNAL MED | 233459 | 1% | 100% | 1 |
2 | HOSP CHINESE PLA 163 | 233459 | 1% | 100% | 1 |
3 | INSERMU896 REG LUTTE CANC VAL DAURELLE PAUL | 233459 | 1% | 100% | 1 |
4 | MED GENE GRPCELL BIOL | 233459 | 1% | 100% | 1 |
5 | MED PATHOBIOL MOL PATHOL | 233459 | 1% | 100% | 1 |
6 | MOL TARGETS MINATO KU | 233459 | 1% | 100% | 1 |
7 | NORRIS COMPREHENS CANC BIOSTAT CORE | 233459 | 1% | 100% | 1 |
8 | OBES INSERMU858 | 233459 | 1% | 100% | 1 |
9 | RANGUEIL MOL MED FEDERATIF RECH 150 | 233459 | 1% | 100% | 1 |
10 | UNIV TOULOUSEBIOMED FEDERAT TOULOUSE | 233459 | 1% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1524 | 6% | 0% | 8 |
2 | ONCOGENE | 1523 | 8% | 0% | 11 |
3 | HUMAN GENE THERAPY | 1099 | 3% | 0% | 4 |
4 | TUMOR BIOLOGY | 843 | 4% | 0% | 5 |
5 | INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY | 787 | 1% | 0% | 1 |
6 | MOLECULAR THERAPY | 567 | 2% | 0% | 3 |
7 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 508 | 1% | 0% | 2 |
8 | MOLECULAR CANCER RESEARCH | 472 | 1% | 0% | 2 |
9 | GENOMICS | 444 | 3% | 0% | 4 |
10 | CLINICAL AND EXPERIMENTAL MEDICINE | 359 | 1% | 0% | 1 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYCLIN G2 | 1883232 | 8% | 73% | 11 | Search CYCLIN+G2 | Search CYCLIN+G2 |
2 | CCNG2 | 1719106 | 7% | 82% | 9 | Search CCNG2 | Search CCNG2 |
3 | CYCLIN G1 | 1694447 | 11% | 48% | 15 | Search CYCLIN+G1 | Search CYCLIN+G1 |
4 | CYCLIN G | 1667561 | 7% | 71% | 10 | Search CYCLIN+G | Search CYCLIN+G |
5 | PATHOTROPIC TARGETING | 933837 | 3% | 100% | 4 | Search PATHOTROPIC+TARGETING | Search PATHOTROPIC+TARGETING |
6 | TARGETED GENETIC MEDICINE | 466919 | 1% | 100% | 2 | Search TARGETED+GENETIC+MEDICINE | Search TARGETED+GENETIC+MEDICINE |
7 | PP2A B GAMMA | 311278 | 1% | 67% | 2 | Search PP2A+B+GAMMA | Search PP2A+B+GAMMA |
8 | ANTISENSE CYCLIN G1 | 233459 | 1% | 100% | 1 | Search ANTISENSE+CYCLIN+G1 | Search ANTISENSE+CYCLIN+G1 |
9 | ASPB10 INSULIN X10 | 233459 | 1% | 100% | 1 | Search ASPB10+INSULIN+X10 | Search ASPB10+INSULIN+X10 |
10 | CYCLIN FAMILY | 233459 | 1% | 100% | 1 | Search CYCLIN+FAMILY | Search CYCLIN+FAMILY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |
rank | cluster_id2 | link |
---|---|---|
1 | 31348 | CYCLIN B1//CCNB1//AGE ASSOCIATED ASPECT |
2 | 12066 | MOMULV TS1//GENE THER Y S//MURINE LEUKEMIA VIRUS |
3 | 26026 | CAK//CDK ACTIVATING KINASE//CDKN3 |
4 | 36739 | CDK11P58//PITSLRE//CDK11 |
5 | 33216 | ABSORBED CLOSE//AUTOINTOXICATION LIVER//DIPIN |
6 | 25315 | OPHIOBOLIN A//COTYLENIN A//OPHIOBOLINS |
7 | 7802 | CIP2A//PP2A//PROTEIN PHOSPHATASE 2A |
8 | 9362 | FOXO1//FOXO//FOXO3A |
9 | 26837 | THERAPEUTIC TRANSGENES//ABT MED MOLEKULARGENET GENDIAGNOST//ANTERIOR SEGMENT CELLS |
10 | 3974 | CYCLIN D1//CYCLIN E//CCND1 |